Celularity, Inc. (CELU)
0.7748
-0.03
(-3.16%)
USD |
NASDAQ |
Aug 24, 16:00
0.7719
0.00 (0.00%)
After-Hours: 20:00
Celularity Enterprise Value : 90.88M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 90.88M |
| August 21, 2026 | 91.61M |
| August 20, 2026 | 90.66M |
| August 19, 2026 | 90.97M |
| August 18, 2026 | 89.78M |
| August 17, 2026 | 88.61M |
| August 14, 2026 | 88.60M |
| August 13, 2026 | 88.59M |
| August 12, 2026 | 88.44M |
| August 11, 2026 | 88.73M |
| August 10, 2026 | 88.34M |
| August 07, 2026 | 88.74M |
| August 06, 2026 | 88.23M |
| August 05, 2026 | 89.71M |
| August 04, 2026 | 88.82M |
| August 03, 2026 | 87.58M |
| July 31, 2026 | 86.86M |
| July 30, 2026 | 88.15M |
| July 29, 2026 | 87.86M |
| July 28, 2026 | 90.46M |
| July 27, 2026 | 90.20M |
| July 24, 2026 | 90.17M |
| July 23, 2026 | 90.45M |
| July 22, 2026 | 91.03M |
| July 21, 2026 | 91.90M |
| Date | Value |
|---|---|
| July 20, 2026 | 91.03M |
| July 17, 2026 | 91.04M |
| July 16, 2026 | 90.69M |
| July 15, 2026 | 91.03M |
| July 14, 2026 | 90.31M |
| July 13, 2026 | 90.31M |
| July 10, 2026 | 89.89M |
| July 09, 2026 | 90.10M |
| July 08, 2026 | 89.58M |
| July 07, 2026 | 89.49M |
| July 06, 2026 | 91.61M |
| July 02, 2026 | 86.41M |
| July 01, 2026 | 85.96M |
| June 30, 2026 | 85.78M |
| June 29, 2026 | 86.02M |
| June 26, 2026 | 86.42M |
| June 25, 2026 | 87.72M |
| June 24, 2026 | 88.04M |
| June 23, 2026 | 88.72M |
| June 22, 2026 | 90.40M |
| June 18, 2026 | 90.23M |
| June 17, 2026 | 91.51M |
| June 16, 2026 | 89.79M |
| June 15, 2026 | 90.74M |
| June 12, 2026 | 89.10M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -58.87M |
| Exicure, Inc. | 5.613M |
| Century Therapeutics, Inc. | 301.71M |
| Absci Corp. | 1.319B |
| Cardio Diagnostics Holdings, Inc. | 0.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.36M |
| Revenue (Quarterly) | 4.104M |
| Total Expenses (Quarterly) | 28.47M |
| EPS Diluted (Quarterly) | -0.8477 |
| Gross Profit Margin (Quarterly) | -123.6% |
| Profit Margin (Quarterly) | -593.6% |
| Earnings Yield | -462.6% |
| Normalized Earnings Yield | -410.69 |